News Focus
News Focus
icon url

StonkMaster

05/04/22 7:24 PM

#465877 RE: Locknload56 #465876

The title of the press release is literally:

Presentation About Phase 3 Trial of DCVax®-L for Glioblastoma To Be Made At New York Academy Of Sciences

icon url

muee88

05/04/22 7:28 PM

#465879 RE: Locknload56 #465876

Yeah I missed it too — it’s in the title.
icon url

biosectinvestor

05/04/22 7:31 PM

#465881 RE: Locknload56 #465876

The title?

Presentation About Phase 3 Trial of DCVax®-L for Glioblastoma To Be Made At New York Academy Of Sciences



reported that a presentation entitled "Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination for Glioblastoma" will be made on May 10, 2022 at 11:10 a.m., by Dr. Linda Liau at the Frontiers of Cancer Immunotherapy Conference of the New York Academy of Sciences.


https://www.prnewswire.com/news-releases/presentation-about-phase-3-trial-of-dcvax-l-for-glioblastoma-to-be-made-at-new-york-academy-of-sciences-301539787.html

And of course they had explained that they were in a quiet period long ago, and would say nothing about the Phase 3 until they released TLD.

So it seems to me, reading between the lines and of course IMHO, this is it.